Results 61 to 70 of about 38,351 (178)

Carbapenemase-producing Enterobacterales infections in COVID-19 patients

, 2021
Carbapenemase-producing Enterobacterales (CPE) infections have been occasionally described in patients with coronavirus disease-19 (COVID-19). We assess the clinical features and outcome of these infections.
Pilar Vizcarra (10330409), Rafael Cantón (147246), Rosa Escudero-Sanchez (11289371), Sabina Herrera (9448655), Pilar Martín-Dávila (10724320), Patricia Ruiz-Garbajosa (3146862), Javier Cobo (4793760), María Isabel Morosini (11267941), Francesca Gioia (8627991), Santiago Moreno (90184), Vicente Pintado (9280955), Jesús Fortún (9381620)   +11 more
core   +1 more source

Antimicrobial Susceptibility Patterns and Proportion of Multidrug‐Resistant Uropathogens in a Remote Tertiary Hospital in Bhutan: A Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background and Aims A surge in antimicrobial resistance and multidrug‐resistant organisms among uropathogens have complicated its management over time. It is imperative to examine epidemiology and local antimicrobial susceptibility patterns to promote evidence‐based management.
Sanga Tenzin, Yeshey Dorjey, Pelden Wangchuk, Chimi Wangmo, Nima Dorji, Ugyen Rinzin, Ugyen Chenzom, Tsheten Wangchuk   +7 more
wiley   +1 more source

Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013

, 2013
The spread of carbapenemase-producing Enterobacteriaceae (CPE) is a threat to healthcare delivery, although its extent differs substantially from country to country.
Walsh T, Buist G, Carmeli Y, Gniadkowski M, Livermore D, Canton R, Giske C, Woodford N, Donker T, Seifert H, Friedrich A, Vatopoulos A, Albiger B, Poirel L, Monnet D, Glasner C, Tambić Andrasević A, European Survey on Carbapenemase Producing Enterobacteriaceae working group, Nordmann P, Glupczynski Y, ROSSOLINI, GIAN MARIA, Grundmann H   +21 more
core   +1 more source

List of metabolites whose concentration (mmol/L; mean ± SD) differed significantly between carbapenemase-positive (+) and carbapenemase-negative (-) K. pneumoniae strains in basal conditions.

, 2018
List of metabolites whose concentration (mmol/L; mean ± SD) differed significantly between carbapenemase-positive (+) and carbapenemase-negative (-) K. pneumoniae strains in basal conditions.
Melissa Salvo (4994417), Luca Laghi (654884), Claudio Foschi (710204), Chenglin Zhu (4994426), Simone Ambretti (463531), Maria Carla Re (467402), Antonella Marangoni (92788)   +6 more
core   +1 more source

Proportion of ESBL and Carbapenemase-producing Enterobacteriaceae from the total of ESBL, and Carbapenemase positive isolates at the University of Gondar Comprehensive Specialized Hospital and Students’ Cafeteria, Northwest Ethiopia, 2021.

, 2022
Proportion of ESBL and Carbapenemase-producing Enterobacteriaceae from the total of ESBL, and Carbapenemase positive isolates at the University of Gondar Comprehensive Specialized Hospital and Students’ Cafeteria, Northwest Ethiopia, 2021.
Desie Kasew (10186174), Feleke Moges (4091917), Azanaw Amare (6589409), Setegn Eshetie (4091920)   +3 more
core   +1 more source

Molecular Diagnostics for WHO Priority Bacterial Pathogens: A Bibliometric Mapping of Diagnostic Platforms, Resistance Markers, and Antimicrobial Resistance Research Trends

MicrobiologyOpen, Volume 15, Issue 5, October 2026.
This bibliometric mapping of 1746 publications (2000–2025) charts molecular diagnostics for WHO priority bacterial pathogens across platforms, targets, and resistance markers. Conventional PCR/NAAT and whole‐genome sequencing emerge as complementary core platforms, and the field evolves from targeted pathogen detection into an AMR‐centered ...
Selahattin Ünlü
wiley   +1 more source

Prevalence and Antibiotic Resistance of Carbapenemase-Producing Gram-Negative Bacteria in Saint Petersburg and Some Other Regions of the Russian Federation

Антибиотики и Химиотерапия, 2020
Carbapenemase-producing gramnegative bacteria, which hydrolyze most ofв-lactams, including carbapenems, is of global health care system threat.
I. V. Lazareva, V. A. Ageevets, T. A. Ershova, L. P. Zueva, A. E. Goncharov, M. G. Darina, Yu. S. Svetlichnaya, A. N. Uskov, S. V. Sidorenko   +8 more
doaj  

Association of antimicrobial use and carbapenemase production (N = 132).

, 2022
Association of antimicrobial use and carbapenemase production (N = 132).
Adane Mihret (456744), Biruk Yeshitela (1804531), Tewachew Awoke (12469092), Brhanu Teka (5172272), Tamrat Abebe (59007), Aminu Seman (12469098), Shemse Sebre (12469095), Abraham Aseffa (108981)   +7 more
core   +1 more source

Genomic and Phenotypic Characterization of Two Novel Enterobacter Phages With EDTA‐Enhanced Antibiofilm Activity

MicrobiologyOpen, Volume 15, Issue 5, October 2026.
Two novel lytic Enterobacter phages, HHH and RZH, displayed targeted antibiofilm activity against MDR Enterobacter cloacae complex biofilms when combined with EDTA. Activity was strongest within a narrow low‐millimolar EDTA window, reducing biofilm biomass and viable burden, while higher EDTA concentrations shifted the interaction towards antagonism ...
Kashif Haq, Zac Newland‐Smith, Martin Figgit, David Lee, Kwabena Duedu   +4 more
wiley   +1 more source

Iran's Escherichia coli AMR Landscape (2010–2025): A One Health Systematic Review and Meta‐Analysis

MicrobiologyOpen, Volume 15, Issue 5, October 2026.
This One Health systematic review and meta‐analysis of 368 studies (2010–2025) reveals that 47.2% of E. coli isolates in Iran are ESBL‐producers, with alarming resistance to penicillins, cephalosporins, and fluoroquinolones. Critically, resistance to last‐resort antibiotics—colistin and ertapenem—is significantly increasing over time.
Arezoo Dehghan, Mina Arabian, Zahra Tahmasebi, Aliasghar Fakhri‐Demeshghieh, Neda Baseri, Ehsan Mostafavi, Farzad Badmasti, Faranak Abnaroodhelleh, Arash Seifi, Fahimeh Bagheri Amiri   +9 more
wiley   +1 more source